Intranasal insulin improves cognition and modulates β-amyloid in early AD

2007823 citationsJournal Article

Authors

Mark A. Reger · Geriatric Research Education and Clinical Center

G. Stennis Watson · Geriatric Research Education and Clinical Center

P. S. Green · Geriatric Research Education and Clinical Center

Charles W. Wilkinson · Mental Illness Research, Education and Clinical Centers

Laura D. Baker · Mental Illness Research, Education and Clinical Centers

Brenna Cholerton · Mental Illness Research, Education and Clinical Centers

Abstract

The results of this pilot study support further investigation of the benefits of intranasal insulin for patients with Alzheimer disease, and suggest that intranasal peptide administration may be a novel approach to the treatment of neurodegenerative disorders.

Topics & Keywords

Biochemical Analysis and Sensing Techniques Regulation of Appetite and Obesity Advanced Glycation End Products research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 70, Issue 6, pp. 440-448

DOI: 10.1212/01.wnl.0000265401.62434.36

Field-Weighted Citation Impact: 28.08